BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 24705027)

  • 1. Role of phosphodiesterase 2 in growth and invasion of human malignant melanoma cells.
    Hiramoto K; Murata T; Shimizu K; Morita H; Inui M; Manganiello VC; Tagawa T; Arai N
    Cell Signal; 2014 Sep; 26(9):1807-17. PubMed ID: 24705027
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Characterization of phosphodiesterase 2A in human malignant melanoma PMP cells.
    Morita H; Murata T; Shimizu K; Okumura K; Inui M; Tagawa T
    Oncol Rep; 2013 Apr; 29(4):1275-84. PubMed ID: 23381931
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of Phosphodiesterase2A in Proliferation and Migration of Human Osteosarcoma Cells.
    Murata T; Shimizu K; Kurohara K; Tomeoku A; Koizumi G; Arai N
    Anticancer Res; 2019 Nov; 39(11):6057-6062. PubMed ID: 31704832
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Rapid regulation of PDE-2 and PDE-4 cyclic AMP phosphodiesterase activity following ligation of the T cell antigen receptor on thymocytes: analysis using the selective inhibitors erythro-9-(2-hydroxy-3-nonyl)-adenine (EHNA) and rolipram.
    Michie AM; Lobban M; Müller T; Harnett MM; Houslay MD
    Cell Signal; 1996 Feb; 8(2):97-110. PubMed ID: 8730511
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hydrolysis of N-methyl-D-aspartate receptor-stimulated cAMP and cGMP by PDE4 and PDE2 phosphodiesterases in primary neuronal cultures of rat cerebral cortex and hippocampus.
    Suvarna NU; O'Donnell JM
    J Pharmacol Exp Ther; 2002 Jul; 302(1):249-56. PubMed ID: 12065724
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tumour growth inhibition and anti-angiogenic effects using curcumin correspond to combined PDE2 and PDE4 inhibition.
    Abusnina A; Keravis T; Zhou Q; Justiniano H; Lobstein A; Lugnier C
    Thromb Haemost; 2015 Feb; 113(2):319-28. PubMed ID: 25230992
    [TBL] [Abstract][Full Text] [Related]  

  • 7. VEGF-induced HUVEC migration and proliferation are decreased by PDE2 and PDE4 inhibitors.
    Favot L; Keravis T; Holl V; Le Bec A; Lugnier C
    Thromb Haemost; 2003 Aug; 90(2):334-43. PubMed ID: 12888882
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differential regulation of human platelet responses by cGMP inhibited and stimulated cAMP phosphodiesterases.
    Manns JM; Brenna KJ; Colman RW; Sheth SB
    Thromb Haemost; 2002 May; 87(5):873-9. PubMed ID: 12038792
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interaction between phosphodiesterases in the regulation of the cardiac β-adrenergic pathway.
    Zhao CY; Greenstein JL; Winslow RL
    J Mol Cell Cardiol; 2015 Nov; 88():29-38. PubMed ID: 26388264
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A PKG inhibitor increases Ca(2+)-regulated exocytosis in guinea pig antral mucous cells: cAMP accumulation via PDE2A inhibition.
    Tanaka S; Tanaka R; Harada S; Kohda Y; Matsumura H; Shimamoto C; Sawabe Y; Marunaka Y; Kuwabara H; Takahashi Y; Ito S; Nakahari T
    Am J Physiol Gastrointest Liver Physiol; 2013 May; 304(9):G773-80. PubMed ID: 23449671
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cyclic GMP regulation of the L-type Ca(2+) channel current in human atrial myocytes.
    Vandecasteele G; Verde I; Rücker-Martin C; Donzeau-Gouge P; Fischmeister R
    J Physiol; 2001 Jun; 533(Pt 2):329-40. PubMed ID: 11389195
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A role for cyclic nucleotide phosphodiesterase 4 in regulation of the growth of human malignant melanoma cells.
    Narita M; Murata T; Shimizu K; Nakagawa T; Sugiyama T; Inui M; Hiramoto K; Tagawa T
    Oncol Rep; 2007 May; 17(5):1133-9. PubMed ID: 17390056
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hydrogen sulfide-mediated stimulation of mitochondrial electron transport involves inhibition of the mitochondrial phosphodiesterase 2A, elevation of cAMP and activation of protein kinase A.
    Módis K; Panopoulos P; Coletta C; Papapetropoulos A; Szabo C
    Biochem Pharmacol; 2013 Nov; 86(9):1311-9. PubMed ID: 24012591
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Erythro-9-(2-hydroxy-3-nonyl)adenine inhibits cyclic-3',5'-guanosine monophosphate-stimulated phosphodiesterase to reverse hypoxic pulmonary vasoconstriction in the perfused rat lung.
    Haynes J; Killilea DW; Peterson PD; Thompson WJ
    J Pharmacol Exp Ther; 1996 Feb; 276(2):752-7. PubMed ID: 8632346
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparative involvement of cyclic nucleotide phosphodiesterases and adenylyl cyclase on adrenocorticotropin-induced increase of cyclic adenosine monophosphate in rat and human glomerulosa cells.
    Côté M; Payet MD; Rousseau E; Guillon G; Gallo-Payet N
    Endocrinology; 1999 Aug; 140(8):3594-601. PubMed ID: 10433216
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Iloprost- and isoproterenol-induced increases in cAMP are regulated by different phosphodiesterases in erythrocytes of both rabbits and humans.
    Adderley SP; Dufaux EA; Sridharan M; Bowles EA; Hanson MS; Stephenson AH; Ellsworth ML; Sprague RS
    Am J Physiol Heart Circ Physiol; 2009 May; 296(5):H1617-24. PubMed ID: 19252089
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cardiac Hypertrophy Is Inhibited by a Local Pool of cAMP Regulated by Phosphodiesterase 2.
    Zoccarato A; Surdo NC; Aronsen JM; Fields LA; Mancuso L; Dodoni G; Stangherlin A; Livie C; Jiang H; Sin YY; Gesellchen F; Terrin A; Baillie GS; Nicklin SA; Graham D; Szabo-Fresnais N; Krall J; Vandeput F; Movsesian M; Furlan L; Corsetti V; Hamilton G; Lefkimmiatis K; Sjaastad I; Zaccolo M
    Circ Res; 2015 Sep; 117(8):707-19. PubMed ID: 26243800
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Activation of cGMP-stimulated phosphodiesterase by nitroprusside limits cAMP accumulation in human platelets: effects on platelet aggregation.
    Dickinson NT; Jang EK; Haslam RJ
    Biochem J; 1997 Apr; 323 ( Pt 2)(Pt 2):371-7. PubMed ID: 9163326
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Phosphodiesterases 2, 3 and 4 can decrease cardiac effects of H
    Neumann J; Voss R; Laufs U; Werner C; Gergs U
    Naunyn Schmiedebergs Arch Pharmacol; 2021 Jun; 394(6):1215-1229. PubMed ID: 33576869
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibitors of phosphodiesterases PDE2, PDE3, and PDE4 do not increase the sinoatrial tachycardia of noradrenaline and prostaglandin PGE₁ in mice.
    Galindo-Tovar A; Vargas ML; Kaumann AJ
    Naunyn Schmiedebergs Arch Pharmacol; 2016 Feb; 389(2):177-86. PubMed ID: 26531832
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.